25 août 2022
Le vaccin de rappel Evusheld améliore la protection des patients atteints de cancers du sang
A third dose of a COVID-19 vaccine can prompt seroconversion in patients with hematologic malignancies who failed to seroconvert after 2 doses, according to a study published in Cancer.